Cancer-Free Bats Hold Secrets to Human Longevity and Health

Genetic Links Between Longevity and Viral Tolerance in Bats

Bats live longer than any other mammal relative to their body size, a trait that scientists are actively investigating to understand human aging. According to Juan Manuel Vazquez, an author of the study at the University of California, Berkeley, bats have evolved an incredible physical capacity to handle diseases and prevent cancer. The research shows that the biological mechanisms protecting bats from infections are the exact same ones guarding them against age-related cellular degradation.

To conduct the research, Vazquez captured, biopsied, and released various bat species, building cell cultures from 259 individuals across 32 species. The investigation focused heavily on the genus Myotis, which displays extreme adaptations for longevity and disease resistance. For instance, the Brandt’s bat (Myotis brandtii) can live for up to 42 years, defying normal mammalian aging trajectories.

How Bats Prevent Cancer and Handle DNA Damage

By mapping the genomes of eight different bat species at a high level of quality, the research team isolated specific biological adaptations used for survival. According to the findings, long-lived bats have developed advanced systems to stop cancer before it takes hold. The little brown bat (Myotis lucifugus), for example, features a heightened ability to clear out damaged cells before those mutations can trigger tumors or severe tissue damage.

Furthermore, these species rely on specific immune factors like PKR. Most species within the Myotis genus have evolved extra copies of the PKR gene, enabling their immune systems to recognize and neutralize a much wider array of pathogens than standard mammalian immune systems can manage.

High Viral Tolerance Versus Traditional Immune Resistance

While most mammals rely on resistance—trying to actively hunt down and destroy invading pathogens—bats utilize a strategy known as viral tolerance. According to the study, bats act as zoonotic reservoirs, meaning they can carry dangerous viruses without ever getting sick. They achieve this by developing mechanisms that suppress the severe inflammation and cellular stress that typically kill other mammals during an infection.

When dealing with RNA viruses—the category responsible for human outbreaks such as the COVID-19 pandemic—bats adjust the quantity of immune genes in their bodies. By generating additional gene copies, they broaden their defensive capabilities and prevent the virus from overwhelming their biological systems.

Implications for Human Medicine and Aging Research

The natural solutions bats use to manage cellular decay and cancer provide a roadmap for human therapeutic development. Vazquez noted that because bats live long spans without falling ill, medical science might not need to treat aging-related conditions and infectious diseases as completely separate domains of medicine.

Researchers suggest that human therapies could eventually draw inspiration from these mammals. By understanding bat biology, scientists hope to find ways to reinforce the human immune system so it does not decline during old age, or to help the body fight off tumors without exhausting immune cells under chronic stress.

Frequently Asked Questions

Why do bats live longer than other mammals?

According to the study published in Nature, bats possess genetic adaptations that link longevity directly to viral tolerance and cancer prevention, allowing them to slow the aging process significantly compared to other mammals.

What is the difference between viral resistance and viral tolerance?

Resistance involves trying to eliminate a pathogen entirely, which often causes damaging inflammation. Tolerance, the strategy used by bats, involves suppressing inflammation and cellular stress so the pathogen can remain in the body without causing disease.

Can humans use bat biology to fight cancer?

Researchers are studying the genetic tricks bats use—such as eliminating damaged cells and expanding immune gene copies—to discover new, unexpected ways of managing cancer and age-related cellular decline in humans.